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Reversibility of Cadmium-Induced Heafth
Ec in Rabbits
by Kazuo Nomiyama* and Hiroko Nomiyama*
Twenty-one male rabbits were divided into three groups: rabbits of two groups were
given pelleted food containing cadmium chloride at a dose level of 300 tg Cd/g over
periods of 44 or 19 weeks. Rabbits of the last group were given ordinary commercial
pelietedfood andserved ascontrols. Cadmium increasedurinaryprotein and amino acid
by week 19 and increased it to a remarkably high level by week 44. After cessation of
cadmium exposure, rabbits of the first group (44 weeks exposure group) showed only
little recovery from cadmiumhealth effects: proteinuria and aminoaciduria were slightly
improved. Depressed hepatic functions were also slightlyimproved, butdid notreturn to
the control level in 24 weeks. Fat and bone metabolism also remained depressed below
the control level. Anemia did not also readily recover. On the other hand, rabbits ofthe
second group (19 weeks exposure) recovered from the effects of cadmium: proteinuria
andaminoaciduria inmostanimalsdisappeared soonafterthe end ofcadmium exposure,
plasma GPTfell after 1 week, andhemoglobin andhematocrit returned to normal in 6-11
weeks. The above results showthat aftercessation ofcadmium exposure, mild cadmium-
induced health effects were reversible in a short period, while more severe effects were
notreadily reversible.
High performance liquid chromatographic (HPLC) profiles of renal and hepatic cad-
mium-thionein (Cd-MT) during and after exposure to cadmium showed no correlation to
thedegreeofcadmiumhealtheffects, andtherefore, didnothelptoelucidate mechanisms
of the recovery from cadmium-induced health effects, probably because cadmium not
bound with metallothionein (non-MT-Cd) is responsible for inducing renal effects.
Introduction
Since Itai-Itai disease was officially established
as a cadmium-induced disease (1), more than
50,000 residents of cadmium-polluted areas in
Japan have taken health checks for preventing
cadmium-induced renal effects and Itai-Itai dis-
ease. Episodes of cadmium pollution have been
reported inthe United States andEuropean coun-
tries as well (2,3). Furthermore, some workers
exposed to cadmium have been reported to suffer
from cadmium health effects (4-6). Once resi-
dents ofCd-polluted areas or workers occupation-
ally exposed to cadmium show effects by accumu-
lating cadmium in the renal cortex at a critical
concentration (7), the adverse health changes in-
duced by cadmium seem essentially irreversible,
because cadmium in the renal cortex hardly de-
creases due to its long biological half-time (7,8)
even long after cessation ofcadmium exposure.
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The present authors, therefore, studied the re-
versibility ofcadmium health effects in animals.
Materials and Methods
Twenty-one male rabbits ofthe Japanese white
strain weighing 2.8 kg were divided into three
groups: 14 rabbits of the first cadmium group
were given pelleted food containing cadmium
chloride at a dose level of300 gg Cd/g for aperiod
of 44 weeks, and four rabbits of the second cad-
mium group were given cadmium at the same
dose for a period of 19 weeks. The remaining
three rabbits were then given ordinary commer-
cial pelleted food and served as controls. Animals
of all groups were given ordinary commercial
pelleted food to study the reversibility of the
cadmium-induced health effects.
Urineandbloodspecimens werecollectedevery
6 weeks for the biochemical determinations. Uri-
nary protein and amino acids were analyzed by
the Tsuchiya-Biuret method (9) and the trinitro-
benzenesulfonicacid(TNBS) method(10), respec-
tively. Urinary protein, glucose, ketone body, oc-NOMIYAMA AND NOMIYAMA
cult blood, urobilinogen and acidity were
evaluated by test tapes (Ames). Creatinine clear-
ance(Cc,) andtubularreabsorption ofphosphorus
(% TRP) were calculated from values ofurine and
plasma creatinine and phosphorus, which were
determined by the Folin-Wu method (11) and the
Fiske-Subbarow method (12), respectively.
Plasma urea nitrogen, uric acid and glucose were
determinedby the diacetylmonoxime method (13)
uricase-peroxidase method (14) and o-toluidine-
boric acid method (15), respectively. Tb evaluate
renal injuries, urinary enzymes were also deter-
mined by the same methods used for as plasma
enzymes mentioned below. Plasma specimens
were subjected to the determinations of plasma
total protein, albumin to globulin ratio (A/G),
GOT, GPT, LDH, alkaline phosphatase (ALP),
andcholinesterase, respectively, byusingreagent
Ibtal Protein AR (Wako), electrophoresis, Japa-
nese Society for Digestive Organs method (16),
Wroblewski method (17), Kind-King method (18)
and benzoylcholine method (19). Cholesterol and
triglyceride were assayed by using the choles-
terol-FA test (Wako) and the triglyceride G-FA
test (Wako). Plasma sodium and potassium were
analyzed by flame photometry, calcium by atomic
absorption spectrophotometry and chloride by
chloridometry.
Cadmium and copper in urine specimens were
determined by Zeeman effect atomic absorption
spectrophotometry (20).
At intervals, animals were sacrificed to deter-
mine tissue cadmium and copper. A 1-gportion of
tissue was ashed with nitric acid and sulfuric
acid, and metal concentration was determined by
atomic absorption spectrophotometry, subtract-
ing the background with a deuterium lamp. For
the tissue metallothionein (MT) composition
analysis, tissues were homogenized in five vol-
umes of 0.25 M sucrose-0.02 M Tris-HCl buffer
(pH 8.0), and the homogenate was centrifuged at
40,000g for 60 min. A 500 IgL portion of the
cytosol was subjected to high performance liquid
chromatographic (HPLC) analysis. MT composi-
tionwas analyzedby Suzuki'sprocedure (21) with
the use of a Tbyo Soda HPLC instrument, Model
803, equipped with a gel permeation column
(Ibyo Soda TSK GEL 3000, 21.5 mm diameter x
600 mm) and 0.05 M ¶fris-HCl buffer (pH 8.0)
containing 0.1% sodium dodecyl sulfate at a flow
rate of3.5 mL/min. The eluate was directly intro-
duced into a Varian-Techtron atomic absorption
spectrophotometer, Model AA 1100, equipped
with abackground corrector BC 6. Atomicabsorp-
tions of heavy metals were continuously moni-
tored. The chart speed was 2 mm/min.
Results
Body Weight
Rabbits of the first cadmium group, receiving
Cd for 44 weeks, showed a depressed weight gain
after week 8 and a decrease in weight after week
33 (Fig. 1). The weight decrease stopped after
cadmium exposure stopped, and began to reverse
25 weeks after cadmium exposure.
Rabbits ofthe second group, which were given
cadmium for 19 weeks, also showed a slight de-
crease in body weight after 14 weeks ofcadmium
exposure. Six weeks after cadmium exposure,
body weight began to increase again.
Urinary Volume
No cadmium-induced changes were observed
during cadmium exposure, but urinary volume of
the first cadmium group increased significantly
21 weeks after cadmium exposure.
Urinary Protein
Urinaryprotein ofthe first cadmium group was
elevated slightly after week 18 and elevated sig-
nificantly after week 31 (Fig. 1). After the cessa-
tion of cadmium exposure, urinary protein de-
creasedbyhalf, but still remainedhigh even at 34
weeks after cadmium exposure.
In the second cadmium group, urinary protein
increased slightly and decreased upon the cessa-
tion ofcadmium exposure. However, urinary pro-
teinwas elevated again afterthe 23rdweek ofthe
recovery period.
Urinary Glucose
Glycosuria was detected in two ofsix rabbits in
the first cadmium group at the end of exposure,
but glycosuria disappeared by 19 weeks after
cadmiumexposure. Onthe otherhand, glycosuria
was found in one of four rabbits in the second
cadmium group at the end ofexposure, but glyco-
suria disappeared on the day after cessation of
cadmium exposure.
Urinary Amino Acids
Urinary amino acids increased in the first cad-
mium group after week 18 (Fig. 1). Immediately
after cessation of cadmium exposure, urinary
amino acids decreased slightly, but it took 26
weeks for the depressed urinary amino acids to
recover to the control level.
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FIGURE 1. Body weight, urinary protein, urinary amino acid, creatinine clearance (Ccr), urinary alkaline phosphatase (ALP),
urinary LDH, plasma total protein and plasma protein albumin to globulin (A/G) ratio: (a) rabbits given cadmium for 44
weeks; (x) rabbits given cadmium for 19 weeks; (A) control rabbits.
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Rabbits of the second cadmium group showed
an increase in urinary amino acids after week 6,
and the level decreased upon the cessation of
cadmium exposure, reaching the control level by
17 weeks.
Creatinine Clearance (Ccr)
Creatinine clearance of the first cadmium
group was not affected during cadmium exposure,
but was depressed after cessation of cadmium
exposure (Fig. 1). Rabbits ofthe second cadmium
group did not show any changes in creatinine
clearance either during or after acadmium expo-
sure.
Thbular Reabsorption of
Phosphorus (%TRP)
Cadmium had no effect on the tubular reab-
sorption ofphosphorus in eitherthefirst orsecond
cadmium groups.
Plasma Uric Acid and Urea Nitrogen
No effects ofcadmium were found.
Urinary Alkaline Phosphatase (ALP)
Urinary ALP increased to two and three times
as much as the control in the first and second
cadmium groups, respectively, by the end ofcad-
mium exposure (Fig. 1). Urinary ALP remained
elevated after cessation of cadmium exposure in
the first cadmium group.
Urinary GOT
Urinary GOT was significantly elevated in the
first cadmium group at week 44 ofcadmium expo-
sure and almost returned to the control level by
44weeks aftercessationofcadmium exposure. No
changes were observed in the second cadmium
group after cadmium exposure except for occa-
sional elevations.
Urinary GPT and LDH
Urinary GPT both in the first and second cad-
mium groups were elevated at the end of cad-
mium exposure, but recovered to the control level
by 28 and 6 weeks after cadmium exposure, re-
spectively.
The elevation andthe recovery in urinary LDH
inthe first cadmium group was similartourinary
GOT (Fig. 1). No changes were observed in the
second cadmium group.
Plasma Protein
The plasma protein in the first cadmium group
was 4.4 g/dL, depressed compared to the control
level of6.2 g/dL at the end ofcadmium exposure
(week 44) (Fig. 1). It barely recovered to the
control level and remained at 5.8 g/dL 33 weeks
after cadmium exposure. No changes were ob-
served in the second cadmium group.
Plasma Albumin to Globulin
(A/G) Ratio
The plasma A/G ratio decreased significantly
with the dose ofcadmium, being 0.44 and 1.53 in
the first and second cadmium groups, respec-
tively, at the end ofcadmium exposure, and 2.58
in the control group (Fig. 1). The depressed
plasma A/G ratio recovered slowly, and the ratio
of the first cadmium group still remained half
that ofthe control group 36 weeks after cadmium
exposure.
Plasma GOT, GPT and LDH
No changes were observed in plasma GOT due
to cadmium exposure. Plasma GPT was elevated
in both the first and second cadmium groups at
the end of cadmium exposure, but recovered to
the control level 1 week after cadmium exposure
(Fig. 2).
Plasma LDH of the first cadmium group in-
creasedafterweek27 andwasthree timesashigh
asthat ofthe control group atthe end ofcadmium
exposure (Fig. 2). It recovered fairly soon after
cessation ofcadmium exposure. No changes were
observed in the second cadmium group.
Plasma Cholesterol and lTiglyceride
In the first cadmium group, plasma cholesterol
was significantly elevated and was 10 times as
high as that of the control level. It decreased
slightly upon the cessation ofcadmium exposure.
It was still slightly higher than in the control
level, even 34 weeks after the end of cadmium
exposure. Nochanges were observed inthe second
cadmium group.
Similar changes were observed in plasma
triglyceride (Fig. 2).
Plasma Sodium, Potassium
and Chloride
No changes due to cadmium exposure were
observed in plasma sodium, potassium or chlo-
ride.
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FIGURE 2. PlasmaGPT,plasma LDH, plasma cholesterol, plasmatriglyceride, plasma ALP, plasma phosphorus, hemoglobin and
hematocrit. Symbols as in Fig. 1.
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Plasma Alkaline
Phosphatase (ALP)
Plasma ALP was depressed by cadmium expo-
sure and was halfofthe control level atthe end of
cadmium exposure (Fig. 2). It was elevated by the
cessation of cadmium exposure, but still re-
mained low for a longperiod. In the second group,
the decreased plasma ALP recovered to the con-
trol level 1 week after cadmium exposure.
Plasma Phosphorus and Calcium
Depressed plasma phosphorus was observed in
the first cadmium group at the end of cadmium
exposure (Fig. 2). It recovered slowly. No changes
were seen in the second group. No specific
changes due to cadmium exposure were observed
in plasma calcium.
Hemoglobin and Hematocrit
Hemoglobin of the first cadmium group de-
creased upon administration of Cd and was 10.5
g/dL (control, 13.7 g/dL) at the end of cadmium
exposure (Fig. 2). Even though cadmium expo-
sure ceased, hemoglobin continuedto decrease for
1.5 weeks andthenbeganto increase. Itremained
below the control level even 55 weeks after the
end ofcadmium exposure. In the second cadmium
group, hemoglobin decreased to 10.4 g/dL at the
end of cadmium exposure, but increased right
after the cessation ofcadmium exposure to reach
the control level by 6 weeks after cadmium expo-
sure.
Hematocrit was also depressed by cadmium
(Fig. 2). Atthe end ofcadmium exposure, Hctwas
38% and 37% in the first and second cadmium
groups, respectively, while it was 45% in the
control group. It recovered to the control level in
11-17 weeks after cadmium exposure. Hemato-
crit in the first cadmium group was again de-
pressed over a period of55 weeks after the end of
cadmium exposure.
Urinary Cadmium
Urinary excretion of cadmium ofthe first cad-
mium group increased with the dose ofcadmium
and reached amaximum of170 jig/day at week 36
(Fig. 3). Immediately after the cessation of cad-
mium exposure, urinary excretion of cadmium
decreased and reached a level of 30 jg/day 2.5
weeks after termination of cadmium exposure
and then decreased slowly to a level of2 jg/day in
34 weeks.
Urinary excretion of cadmium of the second
cadmium group (50-70) gg/day at week 19) de-
creased to 2-4 gg/day level in 2.5 weeks upon the
cessation ofcadmium exposure.
Urinary Copper
Urinary copper was elevated with the dose of
cadmium in the first cadmium group, reaching a
maximum at week 32 and then decreasing (Fig.
3). No further characteristic changes due to cad-
mium were observed during and after cadmium
exposure.
Organ Weight
The liver weight did not change due to cad-
mium exposure (Fig. 3). On the other hand, kid-
ney weight, both the renal cortex and medulla,
increased to two to three times the control level
after 27 weeks of cadmium exposure. It did not
recover to the control level even at 77 weeks after
the cessation of cadmium exposure. The spleen
weight increased far more markedly with the
dose of cadmium, reaching a level five times the
control level, but decreased upon cessation ofcad-
mium exposure.
Tissue Cadmium
Cadmium inthe liver increasedwiththedose of
cadmium, attaining a maximum level of150 jg/g
in week 27 of cadmium exposure and remaining
at this level until week 44 (Fig. 3). After the
cessation of cadmium exposure, cadmium in the
liver decreased very slowly. Cadmium in the re-
nal cortex increasedmore markedly withthedose
ofcadmium to reach a maximum level of300 jg/g
at week 9, and then it decreased gradually to 190
jg/g by week 44. Upon cessation of cadmium
exposure, cadmium in the renal cortex decreased
to 20 jg/g by week 27. Spleen cadmium was also
elevated with the dose of cadmium to reach a
maximum of9 gg/g at 18 weeks. Cadmium in the
spleen decreased upon the cessation of cadmium
exposure to halfofthe maximum level.
Tissue Copper
Copper in the liver increased to 1.5 times that
ofthe controls byweek 18 andthendecreasedto a
little below the control level (Fig. 3). Copper in
the liver was maintained at the same level after
cadmium exposure. Copper in the renal cortex
was also increased by cadmium exposure to a
maximum of7 gg/g, 1.5 times the control level, at
week 18, and then it decreased by half by week
44. Upon the cessation ofcadmium exposure, cop-
per in the renal cortex continued to decrease.
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HPLC Proffles ofTissue
Cadmium-Thionein (MT)
HPLC analysis was performed only for tissue
MTs ofthe first cadmium group (Fig. 4). Two apo-
MTs, MT1 and MT2, were detected both in the
renal cortex andthe liver. Highmolecularweight
cadmium -MT (HMW-Cd) and low molecular
weight cadmium -MT (LMW-Cd) were found as
well. Both MT1 and MT2 in the renal cortex
increased with the dose of cadmium by 9 weeks
and then began to decrease, regardless ofcontin-
ued cadmium administration. After exposure to
cadmium, MTs were detected until week 11 but
not detected in at 40 or 76 weeks. Almost the
same concentration of HMW-Cd was detected in
the renal cortex regardless of the stage of cad-
mium intoxication. LMW-Cd was detectedduring
cadmium exposure and in the 1st week after
cadmium exposure.
MT1 and MT2 in the liver increased with the
dose of cadmium gradually. Even at 76 weeks
after cadmium exposure, MTs were still detect-
able, though in small amounts. Small amounts of
HMW-Cd and LMW-Cdwere detected inthe later
stageofcadmiumintoxication andintheperiodof
recovery from cadmium intoxication.
Discussion
Renal Effects
Rabbits ofthe first cadmium group, whichwere
exposedtocadmiumoveraperiodof44weeks, did
not readily recover from renal effects following
the cessation of cadmium exposure; proteinuria
and aminoaciduria were slightly improved after
cadmium exposure, but were still detected at
week 34 after cadmium exposure. Glycosuria,
whichwasdetectable insomerabbits attheendof
cadmium exposure, disappearedby week 19 after
cadmium exposure. Urinary enzymes also did not
readily recover to the control level long after
cadmium exposure. Ontheotherhand, thesecond
cadmium group, which was exposed to cadmium
over a period of 19 weeks, recovered from renal
effects following the cessation of cadmium expo-
sure: proteinuria and aminoaciduria disappeared
soon after cadmium exposure in most animals.
Enzymuria also disappeared soon after cadmium
exposure.
Some of our previous papers (22-24) reported
findings similartothosewedescribedabove. Rab-
bits that were given subcutaneous injections of
cadmium chloride at a dose level of1.5 mg Cd/kg/
day over aperiod of21 days recovered from renal
effects after the end ofcadmium exposure with a
biological half-time of 13.5 days for urinary pro-
tein, 6.4 days for urinary amino acid, and less
than 6 days for urinary glucose (22). In another
group ofrabbits that were given Cd C12 subcuta-
neously at a dose level of1.5 mg Cd/kg/day for 21
days,proteinuriadisappeared6-9weeksafterthe
end ofcadmium exposure (22). Another group of
rabbits was given pelleted feed containing cad-
mium chloride at a dose level of300 jg Cd/g over
a period of 18 months and then given ordinary
pelleted feed in the following 7 months. After the
endofcadmium exposure, glycosuria disappeared
in 2 months and proteinuria in 5 months (23).
Akahori et al. (24) also reported the reversibility
ofcadmium-inducedrenaleffectsinmonkeys. An-
imals were given pelleted feed containing cad-
miumchloride atdoselevelsof3, 10and30jigCd!
g for 5 years and then given ordinary food forthe
following6months; noimprovement incadmium-
induced nephropathy was observed, except that
glycosuria disappeared after 3 months in a mon-
key given cadmium chloride at a dose level of30
jig Cd/g.
These results may suggest that mild renal ef-
fects are reversible, but severe renal effects are
irreversible. Results of the present experiment
may help clearly to evaluate the different claims
ofPiscator (25) and Tsuchiya (26) on the revers-
ibility ofcadmium health effects in workers. Pis-
cator (25) reported that severe renal effects in
Swedish cadmium workers were irreversible or
evenaggravated aftercessationofcadmiumexpo-
sure. On the other hand, Tsuchiya (26) reported
the contradictory observation that mild renal ef-
fects in Japanese cadmium workers were revers-
ible when they were removed from exposure to
cadmium. Both claims seem quite acceptable to
us because our experimental results clearly indi-
catedthatsevererenal effectswerehardlyrevers-
ibleoraggravated aftercadmium exposure, while
slight renal effects were reversible.
Localization ofCadmium-Induced
Nephropathy
As mentioned before (27), since ALP is located
in the renal proximal tubules and GOT and GPT
are found in the renal distal tubules of rabbits,
enzymuria is a good indicator for detecting the
localization of renal injury in an early stage of
intoxication. As urinary ALP increased more
markedly than GPT and GOT after cadmium
administration, cadmium was thought to injure
proximal tubular cells more severely than distal
tubular cells. Recovery from slight injury at the
distal tubular cells seemed to occur earlier than
recoveryfromsevereinjury attheproximaltubu-
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lar cells, as urinary GPT recovered to the control
level earlier than urine ALP did.
Hepatic Functions
Except for our previous reports (23,24), no data
are available on the recovery from cadmium-
induced hepatic dysfunction. Rabbits were given
pelleted feed containing cadmium chloride over a
period of18 months andthenwere given ordinary
feed for the following 7 months. Cadmium ele-
vated plasma GOT, GPT and LDH and depressed
blood glucose and the plasma protein A/G ratio
after 18 months. Upon the cessation ofcadmium
exposure, plasma GPT and LDH recovered to the
control level in 1 month, and plasma GOT recov-
ered in 5.5 months. No improvement was ob-
served in the plasma protein A/G ratio or in
plasma protein (23). Monkeys that received cad-
mium chloride orally for 5 years did not show any
improvement in hepatic dysfunction 6 months
after removal from cadmium exposure (24).
In the present experiment on rabbits, in the
first cadmium group, plasma protein, protein A/G
ratio, cholesterol and triglyceride did not readily
recover, even at 34 weeks after cadmium expo-
sure. Only plasma LDH returned to the control
level fairly soon after the end of cadmium expo-
sure. On the other hand, hepatic dysfunction in
the second cadmium group readily returned to
the control level; for example, plasma GPT recov-
ered in 1 week, except that the plasma protein
A/G ratio remained low even 36 weeks after cad-
mium exposure.
Anemia
Except for ourprevious report (23), no informa-
tion is available on the recovery from cadmium-
induced anemia. Rabbits were given pelleted food
containing cadmium chloride at a dose level of
300 gg Cd/g over a period of 17 months and then
given ordinary food for the following 7 months.
Depressed hemoglobin and hematocrit were not
improvedeven 7 months aftercadmium exposure.
Results of the present experiment indicate that
some recovery from anemia and return ofhemo-
globin and hematocrit towards control levels oc-
cur immediately after cadmium exposure, but the
levels remained depressed even at week 56 after
cadmium exposure, especially in the first cad-
mium group. This might suggest that severe ane-
mia due to cadmium is not readily reversible,
even after the end ofcadmium exposure.
Tissue Metals
As shown previously (29), tissue metals such as
copper, zinc and cadmium increased in rabbits
given cadmium daily by subcutaneous injections
of cadmium chloride and then decreased a little
earlier or at the time at which renal and hepatic
dysfunction appeared in the animals. Similar
changes were observed in tissue metals during
cadmium exposure in the present experiment.
However, no proof was obtained that tissue
metals decreased as a result ofrenal and hepatic
dysfunction or as aresult ofcessation ofcadmium
exposure. Tissue copper seemed not to decrease
after the end ofcadmium exposure. Owing to the
recovery from renal andhepatic dysfunction, pro-
duction of tissue metallothionein (MT) may in-
crease again. Tissue MT may bind with metals in
the liver and the kidney and may retain tissue
cadmium and copper.
Tissue Metallothioneins (MTs)
High-performance liquid chromatographic
(HPLC) profiles of renal and hepatic cadmium-
thioneins (Cd-MTs) during cadmium exposure
was the same as those in our previous report (29)
on rabbits given cadmium chloride subcutane-
ously on the back at a dose level of0.5 mg Cd/kg/
day over a period of 21 weeks: MT1 and MT2
increased the dose of cadmium until renal and
hepaticdysfunctionappeared. At40 and76weeks
after the end of cadmium exposure, MTs were
barely detectable in the renal cortex and the
liver. Cessation ofcadmium exposure restores the
ability of the kidneys and the liver to produce
MTs which bind with cadmium. The loss ofMTs
at 40 and 76 weeks after the end of cadmium
exposure, therefore, may be associated with the
loss ofthis ability, but notwith the recovery from
cadmium intoxication. Cadmiummaynot existas
Cd-MT, but probably as high molecular weight
cadmium (HMW-Cd) or other chemical forms of
cadmium. Low molecular weight cadmium
(LMW-Cd) was suggested in our previous paper
(29) to be a causative agent for renal and hepatic
dysfunctions. The present experiment might sup-
port the above suggestion, because the amount of
LMW-Cd in the renal cortex is related to appear-
ance and disappearance ofrenal dysfunction dur-
ing and after the end of cadmium exposure. On
the other hand, the amount ofHMW-Cd was not
associated with the degree of renal effects, even
though HMW-Cd has been also suggested as a
causative agentforcadmium renal effects (30,31).
The present HPLC studies on Cd-MTs did not
help to elucidate mechanisms of cadmium-in-
duced renal effects. Therefore, it might be neces-
sary to study cadmium not bound with MT (non-
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MT-Cd) (active cadmium), which might be
responsible for inducing cadmium nephropathy
(29), in future studies.
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